CN Stock MarketDetailed Quotes

600518 Kangmei Pharmaceutical

Watchlist
  • 2.36
  • -0.12-4.84%
Market Closed Nov 15 15:00 CST
32.72BMarket Cap131.11P/E (TTM)

Kangmei Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Assets
Current assets
Money funds
-34.78%773.51M
-37.81%794.97M
-42.33%744.68M
-29.91%1.06B
-40.41%1.19B
-37.62%1.28B
-40.98%1.29B
-37.67%1.51B
214.63%1.99B
190.35%2.05B
Transactional financial assets
-9.90%82.41K
-27.14%72.76K
-33.90%77.54K
-29.42%82.8K
--91.46K
--99.86K
-93.33%117.31K
-77.63%117.31K
----
----
Notes receivable and accounts receivable
22.18%2.31B
22.81%2.23B
11.48%2.2B
3.16%2.08B
19.64%1.89B
16.81%1.82B
23.29%1.97B
43.55%2.01B
-26.11%1.58B
-31.08%1.56B
-Notes receivable
10.54%58.61M
106.61%60.21M
-1.49%54.95M
-1.00%49.46M
-9.83%53.02M
-38.19%29.14M
15.58%55.78M
6.52%49.96M
-15.98%58.8M
12.36%47.15M
-Accounts receivable
22.51%2.26B
21.45%2.17B
11.86%2.14B
3.27%2.03B
20.78%1.84B
18.52%1.79B
23.53%1.92B
44.83%1.96B
-26.45%1.52B
-31.90%1.51B
Other receivables (including interest and dividends)
-10.62%690.11M
-10.58%722.91M
-7.87%738.35M
-10.41%709.24M
-5.41%772.13M
-15.43%808.44M
-15.52%801.41M
-15.10%791.68M
-90.93%816.25M
-89.36%955.98M
-Other receivable
----
-10.58%722.91M
----
----
----
-15.43%808.44M
----
-15.10%791.68M
----
-89.36%955.98M
Advance payment
-20.29%116.85M
-6.45%131.17M
-11.94%156.87M
-32.48%117.93M
-8.37%146.59M
-15.17%140.22M
-5.25%178.15M
22.86%174.66M
-38.00%159.99M
-32.65%165.3M
Inventories
2.56%2.89B
6.44%2.89B
5.96%2.81B
-3.89%2.64B
-15.18%2.81B
-14.33%2.71B
-15.74%2.65B
-13.90%2.75B
-41.12%3.32B
-43.28%3.17B
Receivable financing
331.93%26.29M
19.06%26.82M
-72.65%12.29M
-32.71%16.3M
191.18%6.09M
1,832.20%22.52M
957.21%44.94M
-34.23%24.22M
-97.40%2.09M
-97.73%1.17M
Other current assets
1.07%203.08M
3.77%196.68M
6.25%197.59M
55.64%187.25M
39.64%200.94M
38.47%189.54M
16.73%185.96M
-22.71%120.31M
-72.26%143.89M
-74.46%136.89M
Total current assets
-0.14%7.01B
0.34%6.99B
-3.76%6.86B
-7.78%6.81B
-12.40%7.02B
-13.21%6.97B
-13.48%7.12B
-10.87%7.38B
-56.13%8.01B
-56.27%8.03B
Non Current assets
Other equity investment
-15.81%1.16M
-19.73%1.12M
-18.67%1.13M
-17.19%1.15M
37.33%1.37M
39.75%1.4M
39.12%1.39M
39.12%1.39M
0.00%1M
0.00%1M
Investment real estate
0.12%2.71B
1.15%2.76B
1.29%2.78B
1.40%2.81B
23.36%2.7B
23.46%2.73B
23.61%2.75B
23.42%2.77B
-33.57%2.19B
-33.44%2.21B
Fixed assets
----
-7.24%3.37B
----
----
----
-11.07%3.63B
----
-10.96%3.73B
----
-19.68%4.09B
Constru in process
----
-17.79%172.64M
----
----
----
-20.68%210.01M
----
-18.26%215.5M
----
-92.00%264.75M
Productive biological assets
-11.39%658.45K
-11.08%679.62K
-10.78%700.79K
-10.50%721.96K
-16.63%743.13K
-14.25%764.3K
-11.88%785.47K
-9.50%806.63K
--891.31K
--891.31K
Intangible assets
-8.41%465.12M
-8.39%469.98M
-8.50%474.16M
-7.32%491.02M
-9.92%507.82M
-9.82%513M
-9.75%518.21M
-8.61%529.79M
-45.40%563.73M
-45.46%568.83M
Development expenditure
----
----
----
----
----
----
----
----
----
--268.24K
Goodwill
0.00%106.35M
0.00%106.35M
0.00%106.35M
0.00%106.35M
0.00%106.35M
0.00%106.35M
0.00%106.35M
0.00%106.35M
188.14%106.35M
188.14%106.35M
Long deferred expense
-15.54%61.21M
-21.28%61.48M
-20.79%64.44M
-23.34%66.47M
-20.17%72.47M
-19.48%78.09M
-21.34%81.35M
-21.34%86.71M
-0.58%90.77M
-0.70%96.99M
Deferred tax assets
-1.40%97.53M
1.84%100.4M
6.75%102.37M
4.66%101.48M
59.09%98.92M
59.63%98.59M
56.21%95.9M
59.78%96.97M
-72.76%62.18M
-72.62%61.77M
Usufruct assets
-18.51%182.15M
-15.51%193.57M
-4.34%211.46M
-6.51%217.54M
6.81%223.53M
4.21%229.09M
14.55%221.06M
24.62%232.69M
23.25%209.29M
44.04%219.84M
Other non current assets
45.82%33.63M
48.38%28.38M
62.58%23.43M
49.44%21.9M
-9.97%23.06M
-24.19%19.13M
-44.34%14.41M
-44.38%14.65M
-69.16%25.62M
-71.54%25.23M
Total non current assets
-4.79%7.18B
-4.64%7.26B
-4.27%7.35B
-4.03%7.47B
-0.05%7.55B
-0.31%7.62B
-0.12%7.68B
0.19%7.78B
-42.94%7.55B
-42.81%7.64B
Total assets
-2.55%14.19B
-2.26%14.26B
-4.02%14.21B
-5.86%14.28B
-6.41%14.56B
-6.92%14.59B
-7.03%14.8B
-5.52%15.17B
-50.59%15.56B
-50.60%15.67B
Liabilities
Current liabilities
Short term loan
-63.08%12.2M
99.81%23.41M
15.18%29.96M
2.02%26.14M
24.95%33.05M
-36.04%11.72M
45.24%26.01M
68.84%25.62M
-98.22%26.45M
-98.77%18.32M
Notes payable and accounts payable
14.66%2.54B
19.30%2.52B
6.93%2.41B
-11.98%2.26B
7.73%2.22B
7.55%2.12B
11.38%2.25B
27.22%2.56B
-31.35%2.06B
-36.31%1.97B
-Notes payable
-22.63%37.78M
145.31%89.96M
155.06%89.89M
68.85%51.33M
--48.83M
--36.67M
--35.24M
--30.4M
----
----
-Accounts payable
15.50%2.51B
17.08%2.43B
4.58%2.32B
-12.95%2.21B
5.36%2.17B
5.69%2.08B
9.63%2.22B
25.71%2.53B
-31.35%2.06B
-36.31%1.97B
Contract liabilities
-11.47%172.84M
-23.61%151.91M
-26.51%143.82M
1.12%159.89M
-14.74%195.23M
1.12%198.86M
2.62%195.72M
-18.43%158.12M
-46.02%228.98M
-57.88%196.66M
Advance receipts
-39.89%39.96M
-31.21%45.29M
-35.94%40.55M
4.21%58.65M
-7.65%66.47M
-7.64%65.85M
-21.56%63.31M
-15.52%56.28M
27.98%71.98M
34.64%71.29M
Salaries payable
-62.01%62.64M
-65.32%59.35M
-61.04%67.83M
-57.80%76.48M
-11.83%164.91M
-10.39%171.16M
-9.49%174.08M
-8.34%181.21M
-16.35%187.03M
-13.15%191M
Taxs payable
-57.40%410.54M
-57.89%405.33M
-58.69%406.88M
-42.79%571.3M
12.72%963.71M
9.79%962.66M
-2.50%984.88M
-1.78%998.55M
89.98%854.93M
94.56%876.83M
Other payable (including interest and dividends)
12.34%1.55B
0.29%1.37B
5.36%1.41B
5.54%1.4B
12.38%1.38B
11.18%1.37B
10.66%1.34B
7.51%1.33B
-70.28%1.23B
-70.30%1.23B
-Dividend payable
--2.5M
----
----
----
----
----
----
----
----
----
-Other payable
----
0.29%1.37B
----
----
----
11.18%1.37B
----
7.51%1.33B
----
-48.02%1.23B
Non current liabilities due within one year
-15.56%34.54M
-9.34%36.28M
3.41%39.4M
4.08%40.71M
39.57%40.9M
29.98%40.02M
19.89%38.1M
6.03%39.12M
-99.80%29.3M
-99.79%30.79M
Other current liabilities
-3.04%86.59M
-5.31%84.76M
-2.25%83.4M
-2.77%85.88M
-88.32%89.3M
-44.52%89.51M
-47.82%85.32M
-47.03%88.32M
-73.81%764.37M
-94.47%161.35M
Total current liabilities
-4.64%4.91B
-6.39%4.7B
-10.23%4.63B
-13.99%4.68B
-5.48%5.15B
5.90%5.02B
4.87%5.16B
10.01%5.44B
-79.92%5.45B
-82.61%4.74B
Current liabilities
Long term account payable
----
-4.27%805.12M
----
----
----
195.44%841.01M
----
191.43%853.96M
----
--284.66M
Estimate liabilities
-30.50%621.5M
-15.14%823.83M
-15.04%832.44M
-12.76%855.54M
--894.27M
--970.78M
--979.81M
--980.63M
----
----
Deferred tax liabilities
-21.25%43.85M
-18.62%46.43M
-7.88%50.66M
-6.93%51.68M
--55.69M
--57.06M
--54.99M
--55.53M
----
----
Long term deferred income
-6.00%591.85M
-5.34%603.42M
-5.43%610.9M
-5.40%618.68M
-5.66%629.6M
-5.57%637.46M
-5.50%645.98M
-5.63%653.98M
-32.20%667.34M
-31.98%675.06M
Lease liabilities
-13.61%169.19M
-11.63%176.46M
-1.59%186.62M
-5.51%188.16M
3.64%195.86M
1.77%199.68M
12.78%189.63M
29.96%199.13M
11.91%188.98M
27.94%196.2M
Total non current liabilities
-14.49%2.21B
-9.27%2.46B
-8.36%2.49B
-8.14%2.52B
148.30%2.58B
134.10%2.71B
137.01%2.71B
140.80%2.74B
-93.41%1.04B
-92.67%1.16B
Total liabilities
-7.93%7.12B
-7.40%7.16B
-9.59%7.12B
-12.03%7.2B
19.16%7.73B
31.01%7.73B
29.82%7.87B
34.49%8.18B
-84.88%6.49B
-86.29%5.9B
Shareholders equity
Paid-in capital
0.00%13.86B
0.00%13.86B
0.00%13.86B
0.00%13.86B
0.00%13.86B
0.00%13.86B
0.00%13.86B
0.00%13.86B
178.73%13.86B
178.73%13.86B
Capital reserve funds
0.00%18.78B
0.00%18.78B
0.00%18.78B
0.00%18.78B
0.00%18.78B
0.00%18.78B
0.00%18.78B
0.00%18.78B
62.26%18.78B
62.26%18.78B
Surplus reserve funds
0.00%1.53B
0.00%1.53B
0.00%1.53B
0.00%1.53B
0.00%1.53B
0.00%1.53B
0.00%1.53B
0.00%1.53B
0.00%1.53B
0.00%1.53B
Retained profit
0.98%-25.9B
0.93%-25.89B
0.62%-25.89B
0.39%-25.9B
-8.06%-26.15B
-11.13%-26.13B
-11.21%-26.05B
-11.53%-26B
24.93%-24.2B
26.85%-23.51B
Less:Treasury stock
1.17%1.24B
0.45%1.22B
0.24%1.23B
0.26%1.23B
29.81%1.22B
30.67%1.22B
31.01%1.22B
30.99%1.22B
173.85%940.95M
171.48%932.82M
Other composite income
-278.31%-218.19K
-274.61%-251.97K
-190.09%-121.82K
-173.69%-100.05K
146.61%122.37K
154.89%144.31K
150.94%135.23K
151.15%135.77K
92.67%-262.52K
92.65%-262.93K
Specific reserves
22.05%1.41M
16.33%1.37M
-6.80%1.21M
-1.35%1.28M
-65.76%1.15M
-65.02%1.18M
-61.51%1.3M
-61.51%1.3M
--3.36M
--3.37M
Shareholders equity without minority interests
3.55%7.04B
3.49%7.06B
2.28%7.05B
1.43%7.05B
-24.71%6.8B
-29.86%6.83B
-29.72%6.9B
-30.00%6.95B
178.26%9.03B
185.01%9.73B
Minority interests
1.89%33.93M
9.58%35.75M
5.72%34.33M
-7.16%32.89M
-20.30%33.3M
-22.42%32.63M
-22.27%32.48M
-15.48%35.43M
-68.94%41.79M
-68.60%42.05M
Total shareholder equity
3.54%7.08B
3.52%7.1B
2.29%7.09B
1.38%7.08B
-24.69%6.83B
-29.83%6.86B
-29.69%6.93B
-29.94%6.98B
179.55%9.07B
186.39%9.77B
Total liabilityies and equity
-2.55%14.19B
-2.26%14.26B
-4.02%14.21B
-5.86%14.28B
-6.41%14.56B
-6.92%14.59B
-7.03%14.8B
-5.52%15.17B
-50.59%15.56B
-50.60%15.67B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Tianji International Accounting Firm (Special General Partnership)
--
--
--
Tianji International Accounting Firm (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Assets
Current assets
Money funds -34.78%773.51M-37.81%794.97M-42.33%744.68M-29.91%1.06B-40.41%1.19B-37.62%1.28B-40.98%1.29B-37.67%1.51B214.63%1.99B190.35%2.05B
Transactional financial assets -9.90%82.41K-27.14%72.76K-33.90%77.54K-29.42%82.8K--91.46K--99.86K-93.33%117.31K-77.63%117.31K--------
Notes receivable and accounts receivable 22.18%2.31B22.81%2.23B11.48%2.2B3.16%2.08B19.64%1.89B16.81%1.82B23.29%1.97B43.55%2.01B-26.11%1.58B-31.08%1.56B
-Notes receivable 10.54%58.61M106.61%60.21M-1.49%54.95M-1.00%49.46M-9.83%53.02M-38.19%29.14M15.58%55.78M6.52%49.96M-15.98%58.8M12.36%47.15M
-Accounts receivable 22.51%2.26B21.45%2.17B11.86%2.14B3.27%2.03B20.78%1.84B18.52%1.79B23.53%1.92B44.83%1.96B-26.45%1.52B-31.90%1.51B
Other receivables (including interest and dividends) -10.62%690.11M-10.58%722.91M-7.87%738.35M-10.41%709.24M-5.41%772.13M-15.43%808.44M-15.52%801.41M-15.10%791.68M-90.93%816.25M-89.36%955.98M
-Other receivable -----10.58%722.91M-------------15.43%808.44M-----15.10%791.68M-----89.36%955.98M
Advance payment -20.29%116.85M-6.45%131.17M-11.94%156.87M-32.48%117.93M-8.37%146.59M-15.17%140.22M-5.25%178.15M22.86%174.66M-38.00%159.99M-32.65%165.3M
Inventories 2.56%2.89B6.44%2.89B5.96%2.81B-3.89%2.64B-15.18%2.81B-14.33%2.71B-15.74%2.65B-13.90%2.75B-41.12%3.32B-43.28%3.17B
Receivable financing 331.93%26.29M19.06%26.82M-72.65%12.29M-32.71%16.3M191.18%6.09M1,832.20%22.52M957.21%44.94M-34.23%24.22M-97.40%2.09M-97.73%1.17M
Other current assets 1.07%203.08M3.77%196.68M6.25%197.59M55.64%187.25M39.64%200.94M38.47%189.54M16.73%185.96M-22.71%120.31M-72.26%143.89M-74.46%136.89M
Total current assets -0.14%7.01B0.34%6.99B-3.76%6.86B-7.78%6.81B-12.40%7.02B-13.21%6.97B-13.48%7.12B-10.87%7.38B-56.13%8.01B-56.27%8.03B
Non Current assets
Other equity investment -15.81%1.16M-19.73%1.12M-18.67%1.13M-17.19%1.15M37.33%1.37M39.75%1.4M39.12%1.39M39.12%1.39M0.00%1M0.00%1M
Investment real estate 0.12%2.71B1.15%2.76B1.29%2.78B1.40%2.81B23.36%2.7B23.46%2.73B23.61%2.75B23.42%2.77B-33.57%2.19B-33.44%2.21B
Fixed assets -----7.24%3.37B-------------11.07%3.63B-----10.96%3.73B-----19.68%4.09B
Constru in process -----17.79%172.64M-------------20.68%210.01M-----18.26%215.5M-----92.00%264.75M
Productive biological assets -11.39%658.45K-11.08%679.62K-10.78%700.79K-10.50%721.96K-16.63%743.13K-14.25%764.3K-11.88%785.47K-9.50%806.63K--891.31K--891.31K
Intangible assets -8.41%465.12M-8.39%469.98M-8.50%474.16M-7.32%491.02M-9.92%507.82M-9.82%513M-9.75%518.21M-8.61%529.79M-45.40%563.73M-45.46%568.83M
Development expenditure --------------------------------------268.24K
Goodwill 0.00%106.35M0.00%106.35M0.00%106.35M0.00%106.35M0.00%106.35M0.00%106.35M0.00%106.35M0.00%106.35M188.14%106.35M188.14%106.35M
Long deferred expense -15.54%61.21M-21.28%61.48M-20.79%64.44M-23.34%66.47M-20.17%72.47M-19.48%78.09M-21.34%81.35M-21.34%86.71M-0.58%90.77M-0.70%96.99M
Deferred tax assets -1.40%97.53M1.84%100.4M6.75%102.37M4.66%101.48M59.09%98.92M59.63%98.59M56.21%95.9M59.78%96.97M-72.76%62.18M-72.62%61.77M
Usufruct assets -18.51%182.15M-15.51%193.57M-4.34%211.46M-6.51%217.54M6.81%223.53M4.21%229.09M14.55%221.06M24.62%232.69M23.25%209.29M44.04%219.84M
Other non current assets 45.82%33.63M48.38%28.38M62.58%23.43M49.44%21.9M-9.97%23.06M-24.19%19.13M-44.34%14.41M-44.38%14.65M-69.16%25.62M-71.54%25.23M
Total non current assets -4.79%7.18B-4.64%7.26B-4.27%7.35B-4.03%7.47B-0.05%7.55B-0.31%7.62B-0.12%7.68B0.19%7.78B-42.94%7.55B-42.81%7.64B
Total assets -2.55%14.19B-2.26%14.26B-4.02%14.21B-5.86%14.28B-6.41%14.56B-6.92%14.59B-7.03%14.8B-5.52%15.17B-50.59%15.56B-50.60%15.67B
Liabilities
Current liabilities
Short term loan -63.08%12.2M99.81%23.41M15.18%29.96M2.02%26.14M24.95%33.05M-36.04%11.72M45.24%26.01M68.84%25.62M-98.22%26.45M-98.77%18.32M
Notes payable and accounts payable 14.66%2.54B19.30%2.52B6.93%2.41B-11.98%2.26B7.73%2.22B7.55%2.12B11.38%2.25B27.22%2.56B-31.35%2.06B-36.31%1.97B
-Notes payable -22.63%37.78M145.31%89.96M155.06%89.89M68.85%51.33M--48.83M--36.67M--35.24M--30.4M--------
-Accounts payable 15.50%2.51B17.08%2.43B4.58%2.32B-12.95%2.21B5.36%2.17B5.69%2.08B9.63%2.22B25.71%2.53B-31.35%2.06B-36.31%1.97B
Contract liabilities -11.47%172.84M-23.61%151.91M-26.51%143.82M1.12%159.89M-14.74%195.23M1.12%198.86M2.62%195.72M-18.43%158.12M-46.02%228.98M-57.88%196.66M
Advance receipts -39.89%39.96M-31.21%45.29M-35.94%40.55M4.21%58.65M-7.65%66.47M-7.64%65.85M-21.56%63.31M-15.52%56.28M27.98%71.98M34.64%71.29M
Salaries payable -62.01%62.64M-65.32%59.35M-61.04%67.83M-57.80%76.48M-11.83%164.91M-10.39%171.16M-9.49%174.08M-8.34%181.21M-16.35%187.03M-13.15%191M
Taxs payable -57.40%410.54M-57.89%405.33M-58.69%406.88M-42.79%571.3M12.72%963.71M9.79%962.66M-2.50%984.88M-1.78%998.55M89.98%854.93M94.56%876.83M
Other payable (including interest and dividends) 12.34%1.55B0.29%1.37B5.36%1.41B5.54%1.4B12.38%1.38B11.18%1.37B10.66%1.34B7.51%1.33B-70.28%1.23B-70.30%1.23B
-Dividend payable --2.5M------------------------------------
-Other payable ----0.29%1.37B------------11.18%1.37B----7.51%1.33B-----48.02%1.23B
Non current liabilities due within one year -15.56%34.54M-9.34%36.28M3.41%39.4M4.08%40.71M39.57%40.9M29.98%40.02M19.89%38.1M6.03%39.12M-99.80%29.3M-99.79%30.79M
Other current liabilities -3.04%86.59M-5.31%84.76M-2.25%83.4M-2.77%85.88M-88.32%89.3M-44.52%89.51M-47.82%85.32M-47.03%88.32M-73.81%764.37M-94.47%161.35M
Total current liabilities -4.64%4.91B-6.39%4.7B-10.23%4.63B-13.99%4.68B-5.48%5.15B5.90%5.02B4.87%5.16B10.01%5.44B-79.92%5.45B-82.61%4.74B
Current liabilities
Long term account payable -----4.27%805.12M------------195.44%841.01M----191.43%853.96M------284.66M
Estimate liabilities -30.50%621.5M-15.14%823.83M-15.04%832.44M-12.76%855.54M--894.27M--970.78M--979.81M--980.63M--------
Deferred tax liabilities -21.25%43.85M-18.62%46.43M-7.88%50.66M-6.93%51.68M--55.69M--57.06M--54.99M--55.53M--------
Long term deferred income -6.00%591.85M-5.34%603.42M-5.43%610.9M-5.40%618.68M-5.66%629.6M-5.57%637.46M-5.50%645.98M-5.63%653.98M-32.20%667.34M-31.98%675.06M
Lease liabilities -13.61%169.19M-11.63%176.46M-1.59%186.62M-5.51%188.16M3.64%195.86M1.77%199.68M12.78%189.63M29.96%199.13M11.91%188.98M27.94%196.2M
Total non current liabilities -14.49%2.21B-9.27%2.46B-8.36%2.49B-8.14%2.52B148.30%2.58B134.10%2.71B137.01%2.71B140.80%2.74B-93.41%1.04B-92.67%1.16B
Total liabilities -7.93%7.12B-7.40%7.16B-9.59%7.12B-12.03%7.2B19.16%7.73B31.01%7.73B29.82%7.87B34.49%8.18B-84.88%6.49B-86.29%5.9B
Shareholders equity
Paid-in capital 0.00%13.86B0.00%13.86B0.00%13.86B0.00%13.86B0.00%13.86B0.00%13.86B0.00%13.86B0.00%13.86B178.73%13.86B178.73%13.86B
Capital reserve funds 0.00%18.78B0.00%18.78B0.00%18.78B0.00%18.78B0.00%18.78B0.00%18.78B0.00%18.78B0.00%18.78B62.26%18.78B62.26%18.78B
Surplus reserve funds 0.00%1.53B0.00%1.53B0.00%1.53B0.00%1.53B0.00%1.53B0.00%1.53B0.00%1.53B0.00%1.53B0.00%1.53B0.00%1.53B
Retained profit 0.98%-25.9B0.93%-25.89B0.62%-25.89B0.39%-25.9B-8.06%-26.15B-11.13%-26.13B-11.21%-26.05B-11.53%-26B24.93%-24.2B26.85%-23.51B
Less:Treasury stock 1.17%1.24B0.45%1.22B0.24%1.23B0.26%1.23B29.81%1.22B30.67%1.22B31.01%1.22B30.99%1.22B173.85%940.95M171.48%932.82M
Other composite income -278.31%-218.19K-274.61%-251.97K-190.09%-121.82K-173.69%-100.05K146.61%122.37K154.89%144.31K150.94%135.23K151.15%135.77K92.67%-262.52K92.65%-262.93K
Specific reserves 22.05%1.41M16.33%1.37M-6.80%1.21M-1.35%1.28M-65.76%1.15M-65.02%1.18M-61.51%1.3M-61.51%1.3M--3.36M--3.37M
Shareholders equity without minority interests 3.55%7.04B3.49%7.06B2.28%7.05B1.43%7.05B-24.71%6.8B-29.86%6.83B-29.72%6.9B-30.00%6.95B178.26%9.03B185.01%9.73B
Minority interests 1.89%33.93M9.58%35.75M5.72%34.33M-7.16%32.89M-20.30%33.3M-22.42%32.63M-22.27%32.48M-15.48%35.43M-68.94%41.79M-68.60%42.05M
Total shareholder equity 3.54%7.08B3.52%7.1B2.29%7.09B1.38%7.08B-24.69%6.83B-29.83%6.86B-29.69%6.93B-29.94%6.98B179.55%9.07B186.39%9.77B
Total liabilityies and equity -2.55%14.19B-2.26%14.26B-4.02%14.21B-5.86%14.28B-6.41%14.56B-6.92%14.59B-7.03%14.8B-5.52%15.17B-50.59%15.56B-50.60%15.67B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Tianji International Accounting Firm (Special General Partnership)------Tianji International Accounting Firm (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data